Clinical TrialsSearch results
Number of results: 604
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- Phase II study of modified S-1, docetaxel and cisplatin combination chemotherapy (mDCS) in patients with unresectable metastatic gastric cancer.
- Gastric cancer
- Tokushima-Hokkaido cancer therapy clinical trial group
- 2009-10-01
Other
- Single Arm Phase II Trial of Nitroglycerin Plus Docetaxel in Elderly Untreated Stage IIIB/IV Non-small-cell Lung Cancer
- Non-small-cell lung cancer
- Tohoku University Translational Research Center
- 2009-03-31
Other
- Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer
- Small-cell lung cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinoma
- Thymoma/Thymic carcinoma
- Tohoku University Hospital
- 2010-03-31
Other
- Randomized Phase II Trial Comparing Docetaxel with weekly Paclitaxel and Carboplatin in Elderly Patients with Non-Small Cell Lung Cancer
- Non-small cell lung cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Randomized PhaseII study of amrubicin vs platinum-doublet re-challenge for small cell lung cancer with sensitive relapse
- Small-Cell Lung Cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Usefullness of non-invasive biomarkers in the treatment wiht bronchial asthma
- Bronchial asthma
- Third Department of Internal medicine, Sapporo Medical University School of Medicine
- 2009-03-12
Other
- Study of Assessment for Kidney function by Urinary microalbumin in RAndomized Trial
- Hypertension with diabetic nephropathy
- The University of Tokyo Graduate School of Medicine
- 2008-07-14
Other
- Docetaxel in combination with either cisplatin (DC) or gemcitabine (DG) in unresectable non-small sell lung carcinoma (NSCLC)
- Non-small sell lung carcinoma (NSCLC)
- The Tokyo cooperative oncology group
- 2006-01-23
Other
- Phase III randomized comparative study of combination therapy with CDDP and TS-1 vs. combination therapy with CDDP and Docetaxel in stage IIIB/IV non-small cell lung cancer
- Stage IIIB/IV or ppstoperative recurrent non-small sell lung cancer
- The Tokyo cooperative oncology group
- 2007-04-01